Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors
dc.contributor.author | Koutsilieris, M. | en |
dc.contributor.author | Reyes-Moreno, C. | en |
dc.contributor.author | Choki, I. | en |
dc.contributor.author | Sourla, A. | en |
dc.contributor.author | Doillon, C. | en |
dc.contributor.author | Pavlidis, N. | en |
dc.date.accessioned | 2015-11-24T19:30:45Z | |
dc.date.available | 2015-11-24T19:30:45Z | |
dc.identifier.issn | 1076-1551 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23160 | |
dc.rights | Default Licence | - |
dc.subject | Antineoplastic Agents/*pharmacology | en |
dc.subject | Apoptosis/drug effects | en |
dc.subject | Breast Neoplasms/*drug therapy/*metabolism | en |
dc.subject | Cell Culture Techniques/methods | en |
dc.subject | Cell Division/drug effects | en |
dc.subject | Collagen | en |
dc.subject | Dose-Response Relationship, Drug | en |
dc.subject | Doxorubicin/*pharmacology | en |
dc.subject | Female | en |
dc.subject | Growth Substances/*metabolism | en |
dc.subject | Humans | en |
dc.subject | Insulin-Like Growth Factor I/drug effects/metabolism | en |
dc.subject | Osteoblasts/drug effects/*metabolism | en |
dc.subject | Receptors, Estrogen/metabolism | en |
dc.subject | Transforming Growth Factor beta/drug effects/metabolism | en |
dc.subject | Tumor Cells, Cultured/drug effects/metabolism | en |
dc.title | Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors | en |
heal.abstract | One-third of women with breast cancer will develop bone metastases and eventually die from disease progression at these sites. Therefore, we analyzed the ability of human MG-63 osteoblast-like cells (MG-63 cells), MG-63 conditioned media (MG-63 CM), insulin-like growth factor I (IGF-I), and transforming growth factor beta 1 (TGF-beta1) to alter the effects of adriamycin on cell cycle and apoptosis of estrogen receptor negative (ER-) MDA-MB-231 and positive (ER+) MCF-7 breast cancer cells, using cell count, trypan blue exclusion, flow cytometry, detection of DNA fragmentation by simple agarose gel, and the terminal deoxynucleotidyl transferase (TdT)-mediated nick end-labeling method for apoptosis (TUNEL assay). Adriamycin arrested MCF-7 and MDA-MB-231 cells at G2/M phase in the cell cycle and inhibited cell growth. In addition, adriamycin arrested the MCF-7 cells at G1/G0 phase and induced apoptosis of MDA-MB-231 cells. Exogenous IGF-I partially neutralized the adriamycin cytotoxicity/cytostasis of cancer cells. MG-63 CM and TGF-beta1 partially neutralized the adriamycin cytotoxicity of MDA-MB-231 cells but enhanced adriamycin blockade of MCF-7 cells at G1/G0 phase. MG-63 osteoblast-like cells inhibited growth of MCF-7 cells while promoting growth and rescued MDA-MB-231 cells from adriamycin apoptosis in a collagen co-culture system. These data suggest that osteoblast-derived growth factors can alter the chemotherapy response of breast cancer cells. Conceivably, host tissue (bone)-tumor cell interactions can modify the clinical response to chemotherapy in patients with advanced breast cancer. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/10203574 | - |
heal.journalName | Mol Med | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 1999 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: